Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial

Author(s):
Raps, M.; Rosendaal, F.; Ballieux, B.; Rosing, J.; Thomassen, S.; Helmerhorst, F.; Vliet, H. van
Published
2013
Publication type
Article / Letter to editor
activated protein C resistancenatural estrogenoral contraceptivessex hormone binding globulinthrombotic risk
Date issued
2013-05-31
Language
English
Is part of
Journal of Thrombosis and Haemostasis (2013), Vol. 11, no. 5, p. 855-861
hdl
1887/102373
doi
10.1111/jth.12172